Angiotensin II recognizes two receptor subtypes, AT, and AT2, both of them having been recently cloned. Although AT2 receptors represent 5-10% of angiotensin II receptors in the kidneys of adult rats, their function remains unknown. In the present work, we examined the possible contribution of AT2 receptors to the regulation of pressurenatriuresis in anesthetized rats infused either with the specific AT2 antagonist PD 123319, or with CGP 42112B, an AT2 ligand with agonistic properties. The effects of PD 123319 were examined in a preparation with stable levels of angiotensin II, and in which AT1 receptors were blocked by the specific antagonist losartan. The effects of CGP 42112B were studied in rats deprived of endogenous angiotensin II. AT2 receptor blockade with PD 123319 did not change the renal blood flow while it increased the diuresis and natriuresis. These effects persisted even after full AT1 receptor blockade with losartan. CGP 42112B did not modify the renal blood flow, but dose-dependently decreased urine flow and natriuresis. These results show that, contrary to AT1 receptors, renal AT2 receptors have no effect on total renal blood flow, but blunt the pressure-natriuresis, thus demonstrating that this receptor subtype is involved in a function of importance for body fluid and blood pressure regulation. (J. Clin. Invest. 1995. 95:1394-1397
Introduction
One of the most important effects of the renin-angiotensin system is to influence renal functions through the vasoconstrictor and anti-natriuretic properties of angiotensin 11 (1, 2) . As a consequence, either acutely (3) or chronically (4), angiotensin II shifts to the right the pressure-natriuresis relationship which is of utmost importance in the long-term control of blood pressure (5) . Binding experiments demonstrated that angiotensin II recognizes two receptor subtypes (6) , AT, and AT2,1 both of them having been recently cloned (7) (8) (9) (10) . Although AT2 receptors represent 5 to 10% of angiotensin II receptors in the kidneys of adult rats (11, 12) , their function remains unknown as all the so far studied effects of angiotensin II are blocked by AT, receptor antagonists (13) (14) (15) . The aim of the present work was to examine the possible contribution of AT2 receptors to the regulation of pressure-natriuresis in rats.
Methods
Animals. 10-wk-old male Sprague-Dawley rats (Iffa-Credo, Les Oncins, France) were used in these studies. The rats were allowed at least 1 wk to acclimatize to our laboratory, and were housed in controlled conditions (temperature: 21+1°C; humidity: 60+10%; lighting: 8-20 h). They were fed a standard rat chow containing 0.3% NaCl (Elevage UAR, Villemoisson sur Orge, France) and tap water ad libitum.
Surgical preparation. Pressure-natriuresis was studied using the method of Roman and Cowley ( 16 ) . The right kidney and adrenal gland were removed and the rats allowed 7-10 d to recover. On the day of experiment, the rats were anesthetized with Inactin (100 mg/kg, i.p., Byk-Gulden, Constance, Germany) and placed on a heating blanket (Model 50-6980; Harvard Apparatus, Edenbrige, KY) to maintain the rectal temperature at 37+0.5°C. After tracheostomy, the left jugular vein was cannulated for infusion. Catheters were placed into the left carotid and femoral arteries to sample blood and to record the mean arterial blood pressure through a pressure transducer (Model P23ID; Statham Instrument Division, Gould Inc., Cleveland, OH). After an abdominal incision, the left kidney was exposed and denervated by stripping all the visible renal nerves and coating the renal artery with a 10% solution of phenol in ethanol. The remaining adrenal gland was then removed and the ureter cannulated for urine collection. Two adjustable silastic balloon cuffs were placed around the aorta, one above the renal artery between the superior mesenteric and celiac arteries, the other below the left renal artery so that the renal perfusion pressure could be fixed at different levels. Silk ligatures were placed loosely around the superior mesenteric and celiac arteries and tighten to further elevate the renal perfusion pressure. An ultrasonic flow probe (IR85) placed around the left renal artery allowed to continuously record the renal blood flow using a transonic transit-time flowmeter ( Experimental protocols. In the first protocol, the circulating levels of angiotensin II were maintained stable by an intravenous injection of quinapril (10 mg/kg, i.v.), an angiotensin converting enzyme (ACE)' inhibitor (Parke-Davis, Ann Arbor, MI) given 35 min before the start of the study followed by an intravenous infusion of angiotensin 11 In the second protocol, the effects of CGP 42112B (Ciba-Geigy Ltd, Basel, Switzerland), a specific AT2 receptor ligand (IC50 of 5 x 10-10 and 2 x 10-6 M for AT2 and AT1 receptors respectively) which exhibits agonistic properties (10) were studied in a preparation deprived of endogenous angiotensin II by an intravenous injection of quinapril (10 mg/kg, i.v. 
Results
As shown in Column A of the Fig. 1 , in control conditions, an increase in the renal perfusion pressure from 110 to 150 mmHg, did not change the renal blood flow and glomerular filtration rate but induced an eightfold increase in the natriuresis. The infusion of PD 123319 did not change the renal blood flow and glomerular filtration rate, while it significantly (P < 0.001) increased urine flow and natriuresis, especially at the two highest renal perfusion pressure levels. Column B shows that, when compared to controls, the 10 mg/kg dose of losartan almost doubled the renal blood flow while it did not affect significantly the glomerular filtration rate as well as the relationships between pressure, urine flow and natriuresis. When PD 123319 was added to losartan, renal blood flow and glomerular filtration rate remained unchanged while urine flow (P < 0.001) and natriuresis (P < 0.01) significantly increased. As shown in Column C, a 30 mg/kg dose of losartan did not elevate renal blood flow more than the 10 mg/kg dose but, in addition, significantly enhanced the pressure-natriuresis. When PD 123319 was added to this dose of losartan it was devoid of effects.
As CGP 42112B exhibits agonistic properties, its effects were studied in rats deprived of endogenous angiotensin II. Fig. 2 shows that in control animals, a stepwise increase in renal perfusion pressure did not change renal blood flow and glomerular filtration rate, but increased urine flow and natriuresis to a similar extent as that observed in the first experiments after infusion of PD 123319. In this preparation, CGP 42112B did not modify the renal blood flow and glomerular filtration rate, but dosedependently decreased urine flow and natriuresis. These changes reached statistical significance (P < 0.01 and P < 0.05 for urine flow and natriuresis respectively) with the 10 ,tg/kg per rain dose.
Discussion
The present work demonstrates that in rats receiving a normal sodium diet, acute stimulation of renal AT2 receptors has no effect on total renal blood flow but blunts the pressure-diuresis and natriuresis. Previous attempts to disclose a function for these receptors suggested that AT2 antagonists could elevate the urine volume, chloride and bicarbonate excretion in anesthetized rats (19) or increase free water formation in anesthetized dogs (20) . However, the specificity of these observations was questioned (18, 21) as the doses of the compounds used to A I I block the AT2 receptors were high enough to non-specifically interact with AT, receptors. In the present work, the doses of antagonists and agonist used were maintained low enough to remain highly specific for AT2 receptors. In these conditions, AT2 receptor stimulation or blockade dose-dependently reduced or enhanced the pressure-natriuresis. This effect persisted after administration of 10 but not of 30 mg/kg of losartan, a difference which is likely to be due to a non-specific blockade of AT2 receptors by the high dose of losartan since: (a) the maximal vasodilation and thus the complete AT, blockade was already obtained with the 10 mg/kg dose, and (b) according to Macari et al. (18) , the plasma concentration of losartan following the 30 mg/kg dose might reach the IC50 of this drug for rabbit uterus AT2 receptors.
Such an observation is in good agreement with two recent reports showing that losartan given either acutely (22) or chronically (23) does not affect the pressure-natriuresis or the renal adaptation to a low sodium diet in rats. Since this lack of effect of losartan is in contrast with the natriuretic properties of ACE inhibitors (23, 24) , it supports a role for AT2 receptors as promoters of sodium reabsorption as ACE inhibitors which suppress angiotensin II formation, suppress also the stimulation of both ATI and AT2 receptors.
In addition, it is noteworthy that the effects of both the antagonist (PD 123319) and the ligand with agonistic properties (CGP 42112B) were more marked when the renal perfusion pressure was elevated than when it remained near baseline. This suggests that part of the failure of previous attempts to disclose a function for renal AT2 receptors could have been due to the fact that, in these experiments, renal perfusion pressure was either normal or uncontrolled. The observation that AT2 receptors were found more efficient at high than at normal pressure indicates that they may directly interact with the mechanisms involved in the pressure-natriuresis. Despite extensive work, these mechanisms are not fully understood. The two major current hypothesis rely upon a blood pressure-dependent increase in renal interstitial pressure (25) or in the medullary blood flow (26) . Therefore the location and the site (tubular or vascular) of action of AT2 receptors remains to be determined. However, as far as the present data can fully be extrapolated to physiological conditions, it can be speculated that besides the role of AT1 receptors, angiotensin II through AT2 receptors stimulation is able to prevent the sodium losses which otherwise would accompany any acute increase in blood pressure. In addition, since an abnormal pressure-natriuresis is the hallmark of any form of chronic hypertension (5), an enhanced role of AT2 receptors could well be involved in the development and/or the maintenance of hypertension.
In conclusion, it appears that, in rats fed a normal sodium diet, AT2 receptor stimulation acutely blunts the diuretic and natriuretic responses to blood pressure increases. This effect is likely to contribute to the role of the renin-angiotensin system in body fluid and blood pressure regulation.
